Compass Pathways Plc recorded a cumulative net loss of $-394 million during 12 month ending in the second quarter 2026.
The Healthcare sector has seen employees of 242 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 3791, from total ranking in previous quarter at 4638.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CMPS Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	-2,526,840	-1,146,128	-1,845,269	-1,521,256	-885,263
CMPS's Total Ranking	# 3791	# 4638	# 4098	# 3942	# 3982
Seq. Net Income Change	-	-	-	-	-

CMPS Company Profile >> Back to CMPS Efficiency Comparisons >> Compare CMPS Net Income per Employee to its Competitors

CMPS Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 243
Healthcare Sector	# 630
Overall Market	# 3791

Net Income per Employee Statistics
High	Average	Low
$ -386,756	$ -971,777	$ -2,526,840
(Dec 31 2020)		(Jun 30 2026)

News about Compass Pathways Plc Income per employee

Navigating the Waters Compass Pathways Eyes Investor Confidence Amid Financial Struggles

In the ever-evolving landscape of biotechnology, companies like Compass Pathways plc are at the forefront of transforming mental health treatment through innovative therapies. Based in London and New York, Compass Pathways has gained attention for its commitment to accelerating patient access to evidence-based treatments. As the company prepares to participate in two prominent investor conferences the 7th Annual Evercore ISI HealthCONx Conference and the Piper Sandler 36th Annual Healthcare Conference in December 2024 investor interest remains high. However, a recent financial report suggests that the company is navigating turbulent waters.The company’s management team will host investor meetings and engage in dialogues, aiming to foster relationships and secure support for future endeavors. The back-to-back fireside chats will afford executives the platform to share updates on their innovative treatment options and engage directly with potential investors, hinting at a proactive approach to overcoming financial hurdles. Despite these efforts, financial metrics reveal challenges. For the 12 months ending in the third quarter of 2024, Compass Pathways reported a net loss of $144 million, reflecting significant operational costs that continue to weigh heavily on the bottom line. This loss is particularly pressing considering that the broader Major Pharmaceutical Preparations industry is witnessing its employees benefit from higher income per capita, thereby highlighting the financial strain at Compass in comparison to its peers.

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector

Income per Employee

Income 12 month ending Jun 30 2026

Number of Employees Jun 30 2026

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.